In our overall design (Fig. 1A), in vivo ChaC-MS dissection of AD brain tissues revealed a previously unknown G9a-mediated translational mechanism amenable to directly limit or reverse AD progression or pathogenesis. The gene discussed is EHMT2; the disease is Alzheimer disease.